Centre Hospitalier Universitaire De Poitiers

Haematology and Blood Cancers

Clinical research activity is centred on multiple myeloma, lymphoma, and chronic myeloid leukaemia, with attention to treatment response, disease control, and treatment discontinuation in haematological malignancies.

  • Multiple myeloma
  • Lymphoma
  • Chronic myeloid leukaemia
  • Relapsed or refractory disease

Research also includes older and transplant-ineligible patient populations, reflecting interest in haematologic oncology across different clinical settings.

Breast Cancer

The sponsor supports studies in hormone receptor-positive, HER2-negative breast cancer at high risk of recurrence, with focus on treatment-related toxicity and adjuvant management.

  • HR+, HER2- breast cancer
  • High-risk recurrence
  • Adjuvant therapy
  • Toxicity monitoring

This area reflects involvement in solid tumour oncology alongside haematology.

Infectious and Fungal Diseases

Research includes chronic pulmonary aspergillosis, with interest in antifungal treatment strategies and respiratory infection management in patients with limited immune compromise.

  • Chronic pulmonary aspergillosis
  • Antifungal therapy
  • Respiratory fungal disease
  • Immunocompromised patients

The trial portfolio also touches on vaccination responses in patients receiving cytotoxic treatment.

Surgical and Perioperative Care

Clinical studies address colorectal surgery and prevention of surgical site infection, indicating interest in perioperative infection control and surgical outcomes.

  • Colorectal surgery
  • Surgical site infection
  • Perioperative infection prevention
  • Colorectal care

This area connects operating room practice with antimicrobial and procedural care pathways.

Immunisation in Oncology

The sponsor also studies pneumococcal vaccination in adults receiving cytotoxic chemotherapy, with attention to immune response in cancer-treated populations.

  • Pneumococcal vaccination
  • Immunogenicity
  • Cytotoxic chemotherapy
  • Adult oncology patients

These studies reflect interest in supportive cancer care and infection prevention during treatment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Recruiting

    2 1 1 1
    France
  • Study on the Effectiveness of Pneumococcal Vaccines PCV13 and PPV23 in Adults with Acute Leukemia or Lymphoma Undergoing Chemotherapy

    Recruiting

    3 1 1 1
    France
  • Study Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis

    Recruiting

    3 1 1 1
    France
  • Study of abemaciclib and its connection to severe diarrhea in patients with hormone receptor-positive breast cancer at high risk of return

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France
  • Study on Isatuximab, Pomalidomide, Dexamethasone, and Carfilzomib for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    France
  • Study on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery

    Not recruiting

    3 1 1
    Investigated diseases:
    France